Grace completes CDMO expansion

W.R. Grace has formally opened an expansion of the pharmaceutical CDMO expansion project it began 21 months ago at its site in South Haven, Michigan. The expansion has added 25% more capacity, including a new 15 m3 Hastelloy centrifuge and three 15 m3 multi-purpose chemical reactors.

Formerly owned by Albemarle Fine Chemistry Services, South Haven produces APIs, regulatory starting materials and drug intermediates in quantities from kilos to tons and in compliance with cGMP regulations. It is integrates into another former Albemarle facility at Tyrone, Pennsylvania.